Radiation-induced changes in skin type I and III collagen synthesis during and after conventionally fractionated radiotherapy. 2004

Riitta Keskikuru, and Arja Jukkola, and Jouni Nuutinen, and Vesa Kataja, and Juha Risteli, and Pekka Autio, and Tapani Lahtinen
Department of Oncology, Kuopio University Hospital, FIN-70210 Kuopio, Finland.

OBJECTIVE To measure local changes of collagen metabolism in irradiated breast skin and systemic changes in serum during and after radiotherapy and correlate these changes with skin thickness, erythema and palpable subcutaneous induration. METHODS Aminoterminal propeptides of type I and type III procollagens (PINP and PIIINP, respectively) were measured from skin suction blister fluid (SBF) in 21 breast cancer patients with breast conserving surgery and conventionally fractionated radiotherapy (RT) to a total dose of 50Gy. Suction blisters were induced in the operated and contralateral breast skin before RT, at 2.5 weeks, at the end of RT, and at 1, 4, 7, 12 and 24 months post-treatment. Blood samples for serum were taken simultaneously with SBF induction. Skin thickness of the suction blister sites was measured with a high-frequency ultrasound device. The investigated sites were scored for erythema at the end of RT and palpable subcutaneous induration at 1 and 2 years post-treatment. RESULTS In SBF the mean levels of PINP and PIIINP of the operated breast before RT were about 3-4 times higher than those in the contralateral breast due to the operation-related wound healing. The synthesis of PINP in irradiated breast after RT increased 7.7-fold (P < 0.001) 4 months post-irradiation. The PIIINP synthesis was at maximum at 1 month post-irradiation (P < 0.001). Both synthesis stayed elevated until 2 years. The level of PINP correlated significantly with the palpable skin induration at 1 and 2 years (P = 0.038 and P = 0.003, respectively). The skin thickness of the irradiated breast was highest at 4 months post-treatment and significantly elevated until 1 year. The skin thickness correlated with the PINP level until 7 months and with PIIINP between 4 and 18 months. The PINP/PIIINP ratio reached the maximum at 4 months and stayed elevated until 2 years. No change in mean serum level of PINP was found during or after RT. CONCLUSIONS We demonstrated a maximum and elevated levels for PINP and PIIINP skin collagen metabolism determined from SBF during the 2 years' follow-up. Elevated levels of PINP and PIIINP correlated with the thickening of the skin and subcutaneous induration but not with erythema.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011347 Procollagen A biosynthetic precursor of collagen containing additional amino acid sequences at the amino-terminal and carboxyl-terminal ends of the polypeptide chains. Protocollagen,Procollagen Type M
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004890 Erythema Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes. Erythemas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.

Related Publications

Riitta Keskikuru, and Arja Jukkola, and Jouni Nuutinen, and Vesa Kataja, and Juha Risteli, and Pekka Autio, and Tapani Lahtinen
January 1977, Mechanisms of ageing and development,
Riitta Keskikuru, and Arja Jukkola, and Jouni Nuutinen, and Vesa Kataja, and Juha Risteli, and Pekka Autio, and Tapani Lahtinen
August 2018, Scientific reports,
Riitta Keskikuru, and Arja Jukkola, and Jouni Nuutinen, and Vesa Kataja, and Juha Risteli, and Pekka Autio, and Tapani Lahtinen
January 1998, Ophthalmic plastic and reconstructive surgery,
Riitta Keskikuru, and Arja Jukkola, and Jouni Nuutinen, and Vesa Kataja, and Juha Risteli, and Pekka Autio, and Tapani Lahtinen
March 1980, The Biochemical journal,
Riitta Keskikuru, and Arja Jukkola, and Jouni Nuutinen, and Vesa Kataja, and Juha Risteli, and Pekka Autio, and Tapani Lahtinen
January 1999, Frontiers of radiation therapy and oncology,
Riitta Keskikuru, and Arja Jukkola, and Jouni Nuutinen, and Vesa Kataja, and Juha Risteli, and Pekka Autio, and Tapani Lahtinen
January 1990, Annals of the New York Academy of Sciences,
Riitta Keskikuru, and Arja Jukkola, and Jouni Nuutinen, and Vesa Kataja, and Juha Risteli, and Pekka Autio, and Tapani Lahtinen
January 2023, Clinical oncology (Royal College of Radiologists (Great Britain)),
Riitta Keskikuru, and Arja Jukkola, and Jouni Nuutinen, and Vesa Kataja, and Juha Risteli, and Pekka Autio, and Tapani Lahtinen
May 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
Riitta Keskikuru, and Arja Jukkola, and Jouni Nuutinen, and Vesa Kataja, and Juha Risteli, and Pekka Autio, and Tapani Lahtinen
August 2022, Journal of personalized medicine,
Riitta Keskikuru, and Arja Jukkola, and Jouni Nuutinen, and Vesa Kataja, and Juha Risteli, and Pekka Autio, and Tapani Lahtinen
February 1992, The Journal of investigative dermatology,
Copied contents to your clipboard!